Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
MRI Imaging of Chronobiologic Abnormalities in Depression
This study is ongoing, but not recruiting participants.
Sponsored by: Vanderbilt University
Information provided by: Vanderbilt University
ClinicalTrials.gov Identifier: NCT00178880
  Purpose

The purpose of the study is to identify and understand patterns of brain activity when people are depressed. The study will use an imaging method called Magnetic Resonance Imaging (MRI) which does not involve any exposure to radioactivity or radioactive substances.


Condition
Depression

MedlinePlus related topics: Depression
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Retrospective/Prospective Study

Further study details as provided by Vanderbilt University:

Estimated Enrollment: 60
Estimated Study Completion Date: February 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • WEIGHT: less than or at 20% over ideal weight, as specified in the 1983 Metropolitan Height and Weight Tables. Patients who deviate from these ranges may be reviewed on an individual basis by the Investigator. This criterion is necessary because of mechanical limitations in fitting overweight individuals into the scanner, and the risk of excessive claustrophobic responses if tightly constricted.
  • HEALTH: healthy, ambulatory normal or depressed adults

Exclusion Criteria:

  • Presence of aneurysm clips, cardiac pacemakers, cochlear implants, metal in the eyes, and implanted insulin pumps.
  • Evidence of significant hepatic, gastrointestinal, renal, respiratory, endocrine, hematologic, neurologic, psychiatric, or cardiovascular system abnormalities.
  • Pregnancy.
  • Patients with a known or suspected history of alcohol or drug misuse and/or a positive urine drug screen.
  • Patients who are unwilling or unable to abide by the requirements of the study or who violate the prohibitions and restrictions of the study.
  • Any condition which would make the patient, in the opinion of the Investigator, unsuitable for the study.
  • Patients on antidepressants may not be taking any other medication, except at the discretion of the investigator. Untreated depressed or healthy subjects must be free of all medications except as approved by the investigator.
  • Patients with serious medical illness, history or signs/symptoms of lumbar spine/disc disease or significant laboratory findings.
  • Patients who present significant suicide risk, e.g. with a history of highly impulsive suicide attempts.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00178880

Locations
United States, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37323
Sponsors and Collaborators
Vanderbilt University
Investigators
Principal Investigator: Ronald M Salomon, MD Vanderbilt University
  More Information

Related Info  This link exits the ClinicalTrials.gov site

Study ID Numbers: 010242
Study First Received: September 12, 2005
Last Updated: August 27, 2007
ClinicalTrials.gov Identifier: NCT00178880  
Health Authority: United States: Food and Drug Administration

Keywords provided by Vanderbilt University:
depression
MRI
imaging

Study placed in the following topic categories:
Depression
Mental Disorders
Mood Disorders
Depressive Disorder
Congenital Abnormalities
Behavioral Symptoms

ClinicalTrials.gov processed this record on January 14, 2009